I am a
Home I AM A Search Login

Papers of the Week


Papers: 1 Jun 2019 - 7 Jun 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 Jul


Cephalalgia


39


8

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN.

Authors

Krege JH, Rizzoli PB, Liffick E, Doty EG, Dowsett SA, Wang J, Buchanan AS
Cephalalgia. 2019 Jul; 39(8):957-966.
PMID: 31166697.

Abstract

We assessed the safety profile of lasmiditan, a selective 5-HT receptor agonist without vasoconstrictive activity being developed as an acute therapy for migraine.